Latest News for: Jiaxing clinic

Edit

Latest Updates of Viva Biotech's Portfolio Companies

The Eagle-Tribune 06 Mar 2024
AceLink Therapeutics Announces Publication of Phase 1 Clinical Trial Data Evaluating AL01211 in Healthy Volunteers ... This funding will be used to advance the preclinical R&D work of this pipeline to accelerate its progress towards clinical stage.
Edit

Latest Updates of 9 Viva's Portfolio Companies

Eagle-Tribune 02 Jun 2023
Triumvira to Present Phase I/II Data of TAC01-HER2 in Clinical Trial TACTIC-2 at the 2023 ASCO Annual Meeting ... ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tumor.
Edit

Latest Updates of 6 Viva's Portfolio Companies

The Galveston Daily News 04 Apr 2023
AceLink Presented Phase I Clinical Data of AL01211 and AL00804 During the 2023 WORLD Symposium ... is a privately held clinical stage biopharmaceutical company located in Jiaxing Xiuzhou Biomedicine Guoqian Park, China.
  • 1
×